期刊文献+

参与肺动脉平滑肌细胞增殖信号转导机制及信号转导抑制剂的研究进展 被引量:14

Advances in research on signal transduction mechanisms and their inhibitors for the proliferation of pulmonary artery smooth muscle cells
下载PDF
导出
摘要 肺动脉高压是一种以肺血管阻力升高为特征,最终导致右心功能严重受限、衰竭甚至死亡的慢性进展性疾病。其组织病理学改变主要以肺血管重构为特点,而肺动脉平滑肌细胞在外周血管的异常增殖是肺血管重构的主要病理基础。该文主要对参与肺动脉平滑肌细胞增殖信号转导机制及信号转导抑制剂的研究进展作一综述。 Pulmonary artery hypertension (PAH ) is a chronic progressive disease characterized by a persistent elevation of pul-monary vascular pressure,and the disease would limit the right ventricular function severely,fail the organ and even lead to death in the end.The histopathological change of PAH is fea-tured by the restructuring of pulmonary vessels,and the abnor-mal reproduction of pulmonary artery smooth muscle cells (PASMCs)in peripheral vessels is the major pathological basis of pulmonary vascular restructuring.This paper mainly reviews the research advances on signal transduction mechanisms and their inhibitors in promoting the proliferation of pulmonary artery smooth muscle cells.
出处 《中国药理学通报》 CAS CSCD 北大核心 2015年第5期605-610,共6页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81200043) 广东省自然科学基金资助项目(No S2013040014251)
关键词 肺动脉高压 肺动脉平滑肌细胞 增殖 信号转导机制 信号转导抑制剂 进展 pulmonary artery hypertension PASMCs prolifera-tion signal transduction mechanisms signal transduction inhibi-tors progress
  • 相关文献

参考文献49

  • 1刘晓艳,孟刘坤,李君,魏英杰.分泌型簇蛋白在肺动脉高压大鼠中的表达变化[J].中国药理学通报,2014,30(6):764-768. 被引量:6
  • 2Tuder R M, Archer S L, Dorfmilller P, et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension [ J ]. J Am Coll Cardiol, 2013, 62(25) : D4-12.
  • 3Pabani S, Mousa S A. Current and future treatment of pulmonary hypertension[ J]. Drugs Today (Barc), 2012, 48(2): 133 -47.
  • 4Archer S, Ryan J, Kim G, et al. Epigenetic mechanisms of pul- monary hypertension[J]. Pulm Circ, 2011, 1(3) : 347 -56.
  • 5Karat J, Malty A. PI3K/AKT/mTOR pathway in angiogenesis[ J]. Front Mol Neurosci, 2011, 4:51 - 8.
  • 6Kiss T, Kovacs K, Komocsi A, et al. Novel mechanisms of silde- nafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt[J]. PLoS One, 2014, 9(8) : e104890.
  • 7Wu J, Yu Z, Su D. BMP4 protects rat pulmonary arterial smooth muscle cells from apoptosis by PI3K/AKT/Smadl/5/8 signaling [J].Int JMol Sci, 2014, 15(8) : 13738 -54.
  • 8Garat C V, Crossno T, Sullivan T M, et al. Inhibition of phos-phatidylinositol 3-kinase/Akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in ar- terial smooth muscle cells [ J]. J Cardiovasc Pharm, 2013, 62 (6) : 539 -48.
  • 9Yu L, Quinn D A, Garg H G, et al. Heparin inhibits pulmonary artery smooth muscle cell proliferation through guanine nueleotide exchange factor-H1/RhoA/Rho kinase/p27 [ J ]. Am J Resp Cell Mol, 2011, 44(4): 524-30.
  • 10Chung H, Dai Z, Wu B, et al. KMUP-1 inhibits pulmonary artery proliferation by tm'geting serotonin receptors/transporter and NO synthase, inactivating RhoA and suppressing AKT/ERK phospho- rylation[ J]. Vasc Pharmacol, 2010, 53(5-6) : 239 -49.

二级参考文献31

共引文献26

同被引文献99

  • 1王关嵩,钱桂生,毛宝龄,蔡文琴,陈维中,陈琰.缺氧肺动脉高压大鼠肺组织中白细胞介素6和Janus激酶表达的变化[J].中华结核和呼吸杂志,2003,26(11):664-667. 被引量:8
  • 2王璋,司良毅,廖友斌.大鼠睡眠呼吸暂停综合征动物模型的建立[J].中国实验动物学报,2006,14(1):40-43. 被引量:39
  • 3孔春初,戴爱国.磷酸肌醇3-激酶调控缺氧诱导因子1α对大鼠缺氧性肺动脉高压的作用[J].中国病理生理杂志,2006,22(11):2132-2137. 被引量:13
  • 4Wang H M,Wang Y,Liu M,et al.Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats[J].Can J Physiol Pharmacol,2012,90(11):1506-15.
  • 5Farkas D,Alhussaini A A,Kraskauskas D,et al.Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats[J].Am J Respir Cell Mol Biol,2014,51(3):413-25.
  • 6Takami Y,Nakagami H,Morishita R,et al.Ubiquitin carboxyl-terminal hydrolase L1,a novel deubiquitinating enzyme in the vasculature,attenuates NF-κB activation[J].Arterioscler Thromb Vasc Biol,2007,27(10):2184-90.
  • 7Wang R,Zhang M,Zhou W,et al.NF-kappaB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression[J].J Neurochem,2011,116(6):1160-70.
  • 8Suong D N,Thao D T,Masamitsu Y,Thuoc T L.Ubiquitin carboxyl hydrolase L1 significance for human diseases[J].Protein Pept Lett,2014,21(7):624-30.
  • 9Wilkinson K D,Deshpande S,Larsen C N.Comparisons of neuronal(PGP 9.5)and non-neuronal ubiquitin C-terminal hydrolases[J].Biochem Soc Trans,1992,20(3):631-7.
  • 10Carolan B J,Heguy A,Harvey B G,et al.Up-regulation of expression of the ubiquitin carboxyl-terminal hydrolase L1 gene in human airway epithelium of cigarette smokers[J].Cancer Res,2006,66(22):10729-40.

引证文献14

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部